Cart
sales@molnova.com
Ganirelix Acetate
CAS No. 123246-29-7
Ganirelix Acetate( —— )
Catalog No. M23408 CAS No. 123246-29-7
Ganirelix Acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 172 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 426 | In Stock |
|
| 50MG | 586 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGanirelix Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanirelix Acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist.
-
DescriptionGanirelix Acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGnRHR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123246-29-7
-
Formula Weight1630.4
-
Molecular FormulaC82H117ClN18O15
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCN/C(NCC)=N/CCCC[C@@H](NC([C@@H](NC([C@@H](NC([C@H](NC([C@H](NC([C@H](NC(C)=O)CC1=CC2=CC=CC=C2C=C1)=O)CC3=CC=C(Cl)C=C3)=O)CC4=CN=CC=C4)=O)CO)=O)CC5=CC=C(O)C=C5)=O)C(N[C@H](C(N[C@H](C(N6CCC[C@H]6C(N[C@@H](C(N)=O)C)=O)=O)CCCC/N=C(NCC)/NCC)=O)CC(C)C)=O.CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rabasseda X , Leeson P , J Casta?er. Ganirelix acetate.[J]. Drugs of the Future, 1999, 24(4).
molnova catalog
related products
-
Baceridin
Baceridin is a proteasome inhibitor and a cyclic hexapeptide. Baceridin can be isolated from the culture medium of Epiphytic Bacillus. Baceridin can inhibit cell cycle progression and induce tumor cell apoptosis through a p53-independent pathway. Baceridin can be used in cancer research.
-
HIV-gp120-41-N-A
HIV-gp120-41-N-A
-
Thalidomide-O-amido-...
Thalidomide-O-amido-PEG-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs.
